Global /Germany /Healthcare /Medical Devices /SHL
chevron_leftBack

Siemens Healthineers AG

SHL
XETRA: SHL Delayed
45.63EUR 1.9%
51.71 USD
As of 24 April 2025, Siemens Healthineers AG has a market cap of $57.76B USD, ranking #335 globally and #10 in Germany. It ranks #36 in the Healthcare sector, and #5 in the Medical Devices industry.
Global Rank
335
Country Rank
10
Sector Rank
36
Industry Rank
5
Key Stats
Market Cap
$57.76BUSD
50.97B EUR
Enterprise Value
$73.52BUSD
64.87B EUR
Revenue (TTM)
$25.69BUSD
22.67B EUR
EBITDA (TTM)
$4.36BUSD
3.85B EUR
Net Income (TTM)
$2.25BUSD
1.99B EUR
EBITDA Margin
17%
Profit Margin
8.8%
PE Ratio
25.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Bernhard Montag open_in_new
Employees
72,000
Founded
2017
Website
siemens-healthineers.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.9% 1.4% -12% -15% -11% -11%
Upcoming Earnings
Earnings Date
Wed, May 7

Markets

Exchange Ticker Price
Deutsche Börse Xetra
MIC: XETR
PRIMARY
SHL
Siemens Healthineers AG Registered Shares
ISIN: DE000SHL1006
Shares Out.:
1.119B1 Shares Float: 267.187M2
TV:
SA:
YF:
GF:
BA:
SHL
MS:
45.63 EUR
London Stock Exchange
MIC: XLON
0PMJ
Siemens Healthineers AG Registered Shares
ISIN: DE000SHL1006
TV:
SA:
YF:
GF:
BA:
MS:
45.85 EUR
Borsa Italiana
MIC: XMIL
1SHL
Siemens Healthineers AG Registered Shares
ISIN: DE000SHL1006
TV:
SA:
YF:
GF:
BA:
MS:
44.35 EUR
Frankfurt Stock Exchange
MIC: XFRA
SHL
Siemens Healthineers AG Registered Shares
ISIN: DE000SHL1006
TV:
SA:
YF:
GF:
BA:
SHL
MS:
45.63 EUR
OTC Markets
MIC: OTCM
SEMHF
Siemens Healthineers AG Registered Shares
ISIN: DE000SHL1006
TV:
SA:
YF:
GF:
BA:
MS:
48.95 USD
OTC Markets
MIC: OTCM
SMMNY
Siemens Healthineers AG ADR
ISIN: US82622J1043
TV:
SA:
YF:
GF:
BA:
MS:
25.62 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Similar Companies

Industry: Medical Devices (Germany)
Name
Market Cap diff.
Eckert & Ziegler SE
EUZ
$1.25B
1.1B EUR
-98%
Drägerwerk AG & Co. KGaA
DRW8
$1.15B
1.02B EUR
-98%
Stratec SE
SBS
$338.19M
298.43M EUR
-99%
VIROMED MEDICAL AG
VMED
$115.89M
102.26M EUR
-100%
aap Implantate AG
AAQ1
$22.22M
19.6M EUR
-100%
Industry: Medical Devices (Global)
Name
Market Cap diff.
Abbott Laboratories
ABT
$225.18B
290%
Boston Scientific Corp.
BSX
$146.31B
153%
Stryker Corp.
SYK
$136.3B
136%
Medtronic plc
MDT
$107.41B
86%
Edwards Lifesciences Corp.
EW
$41.27B
-29%